Synthesis and application of advanced fluorescent probes (#165)
7:30 PM
Detection of bioactive peptides including gonadotrophin-releasing factors (GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) (#166)
7:30 PM
Photooxidation of oxazoles – a new approach to solid-phase peptide synthesis (#167)
7:30 PM
Development of novel relaxin-3 analogues for blood-brain barrier penetration (#168)
7:30 PM
Phosphorylation of α-synuclein induces distinct strains and propagation properties (#169)
7:30 PM
Dichloroacetone – A robust approach to acetone-linked bicyclic dimer peptides (#170)
7:30 PM
Synthesis of Peptide Natural Products Enabled by New Strategies for Late-Stage Modification (#171)
7:30 PM
The role of charge regulation in the interaction between oligo-peptides and polyelectrolytes (#172)
7:30 PM
Insulin fatty acid acylation scan: Discovery of Insulin 327, an acylated hepato-preferential insulin analogue with high insulin receptor affinity (#173)
7:30 PM
Robust methodology for assembling peptides with tryptophan C-mannosylation (#174)
7:30 PM
Peptide modulating tension in cell membranes: the regulation of cell movement and morphology via actin remodeling (#175)
7:30 PM
Tyrosine sulfation is an important post-translational modification in anti-inflammatory peptides from blood-feeding organisms. (#177)
7:30 PM
The New Kid On The Block: Discovery and development of NaV channel inhibitor and µ-conotoxin NgIIIA (#178)
7:30 PM
Peptide cyclisation using a pyridine-2,6-dicarbonitrile linker (#179)
7:30 PM
Structure-activity study of the analgesic NaV1.7 inhibiting venom peptide Pn3a (#180)
7:30 PM
Chemical strategies to tune potency, selectivity and stability of neuropeptides (#181)
7:30 PM
Design and synthesis of a PD-1 binding peptide and evaluation of its anti-tumor activity (#182)
7:30 PM
A Zn(II)-catalyst permits bis-thioether peptide stapling under non-basic conditions (#183)
7:30 PM
Noncanonical peptides as probes and inhibitors for flavivirus proteases (#184)
7:30 PM
Identification and Optimisation of a Lead Bromodomain Inhibitor (#185)
7:30 PM
Membrane-bound structure and membrane selectivity of cationic antimicrobial peptide Hymenochirin-1Pa and its D9K analog (#186)
7:30 PM
Evaluation of biological activity of frog skin-derived peptide, ranatensin (#187)
7:30 PM
Thiol-cyanobenzothiazole ligation: an efficient preparation of peptide-oligonucleotide conjugates (#188)
7:30 PM
The Structural Features of an Ancient Peptide Family Buried within Vicilin Precursors. (#189)
7:30 PM
Cyclic peptide conjugates: their mode-of action and interaction with cell membranes (#190)
7:30 PM
Cyclic peptides to probe the internal interactome of PDZ domains (#192)
7:30 PM
Decoding the complex regulation of cone snail venoms: connecting evolution and drug discovery (#193)
7:30 PM
Novel methods for inhibiting amyloidogenesis in the presence of peptides in order to block hydrophobic interaction (#194)
7:30 PM
Cytosolic Delivery of Macromolecules by Endosomolytic Cationic Helical Peptide (#195)
7:30 PM
Exploring the oxytocin receptor as a novel target for breast cancer (#196)
7:30 PM
Affinity-based functionalization of biomedical polymeric micelles through polymer-binding peptides (#197)
7:30 PM
Backbone cyclization of native α-conotoxin CIA: Influences on structure and bioactivity (#198)
7:30 PM
The use of peptide-membrane interactions in the design of selective and potent sodium channel inhibitors (#199)
7:30 PM
Discovery of tight binding inhibitors of hip1 a mycobacterium tuberculosis drug target (#200)
7:30 PM
Conformational diversity in the neurotensin peptide upon binding neurotensin receptor 1 may drive receptor activation (#201)
7:30 PM
Discovery and mechanistic investigations of ultrashort amphiphilic peptides that exhibit potent inhibition of Cryptococcus neoformans (#202)
7:30 PM
Tripeptide-induced mechanical property modulation of mesenchymal stem cells stimulates proliferation and wound healing (#203)
7:30 PM
Enhancing activity by combining antimicrobial peptides and antibiotics (#204)
7:30 PM
Evolving Peptide G Protein-Coupled Receptors (GPCRs) to Facilitate Structural Studies Using a Novel Lentiviral Based Method of Directed Evolution (#205)
7:30 PM
Peptide based hydrogen sulfide responsive nanostructures for biomedical applications (#206)
7:30 PM
Analysis of granulin peptide folding (#207)
7:30 PM
Synthesis and biological activity of celogentin analogues (#208)
7:30 PM
Iterative optimization of the cyclic peptide SFTI-1 yields potent inhibitors of neutrophil proteinase 3 (#209)
7:30 PM
Taking active steps to improving the pharmacokinetics of disulfide-rich peptides (#210)
7:30 PM
μ‐Conotoxin KIIIA isomer selectivity on human voltage gated sodium channels (#211)
7:30 PM
Enzymatic ligation of Nav1.7-inhibiting gating modifier and pore blocker toxins (#212)
7:30 PM
Exploration of amyloidogenic core β-sheet and the FEL-mediated dissociation of amyloid fibrils in SAA (#213)
7:30 PM
The characterization of triglyceride-based nanodroplets and their interaction with lipid specific peptides and proteins (#214)
7:30 PM
A fluorescent protein-tagged peptide toxin as a tool for KV1.3 visualisation (#215)
7:30 PM
Combinatorial peptide libraries in venoms of Australian nettle caterpillars (#216)
7:30 PM
From sunflower to skin cancer: Development of melanocortin receptor-1 agonists based on the cyclic peptide framework of sunflower trypsin inhibitor-1 (#217)
7:30 PM
Development of a lentiviral nanobody screening platform against peptide GPCRs (#218)
7:30 PM
Delivery of a peptide-based vaccine against Group A Streptococcus with the help of cell penetrating peptides (#219)
7:30 PM
Anchoring epitopes to improve grafted peptide structure and activity (#220)
7:30 PM
A*STAR Peptide Engineering Platform (PEP): Targeting Macrocyclic Modalities for Protein-Protein Interactions (#221)
7:30 PM
In-cell structure determination of an antimicrobial peptide by DNP solid-state NMR (#222)
7:30 PM
Peptidomimetics targeting the SOCS-SH2 domain (#223)
7:30 PM
Receptor-Mediated MAPK and Akt Signaling are Maintained in Gamma-Irradiated FroZen Cells (#224)
7:30 PM
Synthesis and Evaluation of a Library of Self-Adjuvanting Peptide and Protein Vaccines against Mycobacterium tuberculosis (#225)
7:30 PM
Development of a single-chain peptide agonist for the G-protein-coupled receptor, RXFP1 (#226)
7:30 PM
Improving in vivo analgesia through glycosylation of bilorphin, a biased μ-opioid derived from a novel tetrapeptide class found in an Australian fungus (#227)
7:30 PM